The Greater Phoenix Chamber of Commerce has selected the Translational Genomics Research Institute (TGen) for one of its 2014 Impact Awards. TGen was selected among small to medium business in…
University of Arizona researchers have been awarded a $200,000 two-year seed grant by the Flinn Foundation through its Promoting Translational Research in Precision Medicine grants program to define the pulmonary…
A short-term study led by C. Kent Kwoh, MD, director of the University of Arizona Arthritis Center, and a collaborative team of researchers has found that oral glucosamine supplementation is…
Under a new grant from the National Institutes of Health (NIH), Phoenix Children’s Hospital, Barrow Neurological Institute and the Translational Genomics Research Institute (TGen) are studying the role of extracellular…
In association with its 50th anniversary, the American Society of Clinical Oncology (ASCO) has named Daniel D. Von Hoff, M.D., FACP, one of ASCO’s 50 Oncology Luminaries, celebrating 50 doctors…
Researchers at the Translational Genomics Research Institute (TGen) have discovered a protein, Mcl-1, that helps enable one of the most common and deadly types of cancer to survive radiation and…
Dr. Daniel D. Von Hoff, Distinguished Professor and Physician-In-Chief of the Translational Genomics Research Institute (TGen), was inducted into the Joshua Lederberg Society for his work in developing the drug…
Researchers at the Translational Genomics Research Institute (TGen) and physicians at Mayo Clinic’s Individualized Medicine Clinic have personalized drug treatments for patients with cholangiocarcinoma using genomic sequencing technologies. Potential new…
The Ben & Catherine Ivy Foundation has awarded an $885,294 grant to Barrow Neurological Institute for brain cancer research. The Ivy Foundation is the largest privately funded brain cancer research foundation…
Investments by state governments in their own state universities can yield large returns and help create new industries. In Arizona, telemedicine is a good example of a success story. The…
The Alzheimer’s Prevention Initiative (API) trial in cognitively healthy individuals has reached a significant milestone with the first participants in Colombia receiving doses of an experimental anti-amyloid antibody, crenezumab designed…
The Ben & Catherine Ivy Foundation today announced a $3 million grant to the Translational Genomics Research Institute (TGen), Nemucore Medical Innovations Inc., and Barrow Neurological Institute at St. Joseph’s…
